Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-22, Stock:JNJ, The news for the past five days is as follows:
2019-10-15: NEWS1: Dow Jones Futures: 5 Big Movers Late; Stock Market Leader ASML On Tap With Earnings.NEWS2: US Indexes Close Higher Tuesday With 3rd-Quarter Earnings Kickoff.NEWS3: Oklahoma judge says he miscalculated award in J&J opioid case by $107 million.NEWS4: Wall Street Advances Tuesday.NEWS5: J&J Says No Legal Reserves Needed Amid Wave of Lawsuits.NEWS6: Drug Distributors Could Be Nearing An $18 Billion Opioid Settlement.NEWS7: Drug distributors in talks to settle opioid litigation for $18 bln - WSJ.NEWS8: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS9: UPDATE 1-Missouri appeals court overturns $110 mln Johnson & Johnson talc verdict.NEWS10: JNJ, JP Morgan and UnitedHealth all Beat, Goldman Sachs Misses.NEWS11: Missouri appeals court overturns $110 million Johnson & Johnson talc verdict.NEWS12: PreMarket Prep Recap: Impressive Bank Earnings, Aphria Sparks Rally In Marijuana Sector.NEWS13: Jim Cramer: Here's What We Can Bask in Today.NEWS14: Johnson & Johnson (JNJ) Surpasses Q3 Earnings and Revenue Estimates.NEWS15: US STOCKS-Wall Street advances as earnings season hits the road running.NEWS16: Johnson & Johnson on mushrooming lawsuits: 'We're targets, unfortunately'.NEWS17: US STOCKS-Wall Street gains after strong start to earnings season.NEWS18: What Investors Need to Know About Johnson & Johnson's 3rd-Quarter Results.NEWS19: Johnson & Johnson Is Facing Mounting Legal Fees — Is JNJ Stock A Safe Buy?.NEWS20: Johnson & Johnson Stock Is Up After Its Earnings Beat.NEWS21: The Dow Is Up Because Strong Earnings Can Make Us Forget About Trade.NEWS22: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS23: J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion.NEWS24: J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View.NEWS25: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS26: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS27: Q3 Results Begin: Can We Avoid an Earnings Recession?.NEWS28: Dow up 280 points on gains for UnitedHealth, JPMorgan Chase stocks.NEWS29: Initial Q3 Results Are Better-Than-Expected.NEWS30: For J&J and UnitedHealth, Making Money's Easy for Now.NEWS31: US STOCKS-Wall St rises after upbeat start to earnings season.NEWS32: Bank Earnings Quartet Mostly In Tune, Led By Strength At JPMorgan, Citigroup.NEWS33: Relmada Shares Hit 4-Year High As Depression Drug Aces Midstage Trial.NEWS34: US STOCKS-Wall St headed higher on strong earnings start.NEWS35: UnitedHealth, J.P. Morgan Chase, Johnson & Johnson earnings beats adding combined 119 points to the Dow.NEWS36: UnitedHealth, Johnson & Johnson share gains lead Dow's 135-point climb.NEWS37: For ESG investors, the newest challenge is separating fact from ‘greenwashing’.NEWS38: The Dow Is Rising as Fed Policy, Earnings and Brexit Push Trade Aside.NEWS39: Here's Why You Should Hold on to CONMED (CNMD) Stock for Now.NEWS40: J&J (JNJ) Beats Q3 Earnings & Sales, Shares Rise.NEWS41: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS42: Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements.NEWS43: Dow Jones Futures: Snoozing Stock Market Gets Jolt As 4 Dow Giants Report.NEWS44: J&J boosts full-year outlook but warns of uncertain legal costs.NEWS45: UPDATE 2-Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS46: Johnson & Johnson Earnings, Sales Unexpectedly Rise; JNJ Stock Climbs.NEWS47: Johnson & Johnson shares rise after earnings beat estimates, company raises guidance.NEWS48: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS49: Johnson & Johnson Reports 2019 Third-Quarter Results.NEWS50: [video]Stocks Rise as Earnings From JPMorgan Chase and UnitedHealth Boost Dow.NEWS51: Johnson & Johnson to Host Earnings Call.NEWS52: Johnson & Johnson Tops Q3 Profit Forecast, Lifts 2019 Guidance: Pharma Surprises.NEWS53: J&J Earnings, Revenue Beat in Q3.
2019-10-16: NEWS1: Johnson & Johnson Stock Rebounds After Earnings.NEWS2: Johnson & Johnson's 3 Most Profitable Lines of Business (JNJ).NEWS3: PreMarket Prep Recap: Stormy Outlook For Cloud Stocks, Opioid Makers Rally On Settlement Talks.NEWS4: Stock market news: October 16, 2019.NEWS5: Large Option Traders Aren't Buying The Johnson & Johnson Rally.NEWS6: Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom.NEWS7: Dow Gets A Boost From These 3 Key Stocks, But Software Thumps Nasdaq.NEWS8: Dow Gets A Boost From This Big Stock, But Software Thumps Nasdaq.NEWS9: St. Louis court tosses $110M talc verdict against Johnson & Johnson.NEWS10: 'High-level dope dealers': Democratic candidates sound off on big pharma.NEWS11: Opioid Drug Companies Rally On Hopes of Broader Settlement.NEWS12: McKesson, Cardinal Health, AmerisourceBergen stocks surge after WSJ report of $18 billion settlement talks.NEWS13: Dow flat in spite of gains in Johnson & Johnson, Dow Inc. shares.NEWS14: J&J Makes $4 Billion Opioid Offer as Distributors Seek Deal.NEWS15: JNJ Beats, Ups View: Healthcare ETFs to Buy.NEWS16: Stock Market News for Oct 16, 2019.NEWS17: Cardinal Health Stock, Other Drug Distributors, Jump on Possible Opioid Settlement.NEWS18: The S&P 500 may be ‘one decent day of gains’ away from a ‘breakout’.NEWS19: Dow Jones Futures: Chip Leader ASML Leads Key Movers As Stock Market Rally Steps Up.NEWS20: Market Morning: Brexit Back’n’Forth, Carrie Lam Booed Off Stage, Buffett Wants BofA, Balkman Blunders.NEWS21: Dow Jones Futures: After Bullish Stock Market Rally; Chip Leader ASML Leads Key Movers.NEWS22: Johnson & Johnson Gains On Opioid Settlement Reports; Distribution Firms Surge.NEWS23: Opening Quote: Asos FY profits fall by two-thirds.NEWS24: Dow Jones Futures: China Tensions Rise Over Hong Kong After Bullish Stock Market Rally; ASML On Tap.NEWS25: UPDATE 3-Three drug distributors in talks to settle opioid litigation for $18 bln -WSJ.
2019-10-17: NEWS1: Edited Transcript of JNJ earnings conference call or presentation 15-Oct-19 12:30pm GMT.NEWS2: Drug Suppliers Reportedly Near $50 Billion Deal In Opioid Lawsuits.NEWS3: Top Stock Reports for Johnson & Johnson, Boeing & Pfizer.NEWS4: Why Health Care Stocks Can Rebound Despite 2020 Election Turmoil.NEWS5: UPDATE 1-J&J agrees to pay about $117 mln to settle U.S. states' mesh probe.NEWS6: Johnson & Johnson agrees to pay about $117 million to settle U.S. states' mesh probe.NEWS7: Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2019.NEWS8: Judge summons drug company CEOs to court to discuss opioid settlement: source.NEWS9: Teva Stock Is Jumping After Reports It May Trade Generic Drugs for an Opioid Settlement.NEWS10: Dow's 69-point jump led by gains for shares of Johnson & Johnson, JPMorgan Chase.NEWS11: Drug Distributor Stocks Rally Amid Opioid Talks.NEWS12: Market Morning: Chinese Aircraft Carriers, DUP Sours on Brexit Deal, Big Opioid Settlement.NEWS13: Broad opioid settlement talks heat up as federal trial looms.
2019-10-18: NEWS1: US Stocks Decline Friday.NEWS2: US Indexes Close Lower Friday After Weak China Data Report.NEWS3: J&J Recalls Lot of Baby Powder After Asbestos Trace Found.NEWS4: Stocks - S&P Knocked Down by Boeing, JNJ, China.NEWS5: [video]Game Plan for Earnings: Cramer's 'Mad Money' Recap (Friday 10/18/19).NEWS6: Boeing and JNJ Drag Dow Lower, End Week in Red.NEWS7: J&J Stock Plunges After FDA Test Finds Asbestos In Baby Powder.NEWS8: US STOCKS-Boeing, J&J, dismal China data drag Wall Street lower.NEWS9: US STOCKS SNAPSHOT-Boeing, J&J pull down Wall Street along with weak China data.NEWS10: 5 Top Stock Trades for Monday: BA, MSFT, JNJ, SNAP, AXP.NEWS11: Johnson & Johnson recalls baby powder, the subject of a $4.7 billion St. Louis verdict.NEWS12: Bad Day On Stock Market Continues; These Two Stocks Took Down The Dow.NEWS13: Boeing, Johnson & Johnson share losses lead Dow's 200-point drop.NEWS14: US STOCKS-Wall Street weighed by Boeing, J&J, bleak China data.NEWS15: FDA alerts consumers of J&J baby powder recall, says it stands by tests.NEWS16: Boeing's stock selloff a triple-digit point drag on the Dow.NEWS17: US STOCKS-Wall St pressured by J&J, Boeing; growth worries linger.NEWS18: Tech Stocks Lead Selling As Boeing, J&J Hit The Dow Jones Industrial Average.NEWS19: Johnson & Johnson Stock Falls on Baby Powder Recall.NEWS20: Jim Cramer: Johnson & Johnson's Baby Powder Recall Is 'Suboptimal'.NEWS21: UPDATE 4-Opioid settlement talks falter, landmark trial expected Monday -attorney.NEWS22: Dow industrials skid 200 points lower in midday action as J&J and Boeing's stock produce 100-point headwind.NEWS23: US STOCKS-Wall Street pressured by J&J, global growth concerns.NEWS24: Johnson & Johnson, Boeing share losses lead Dow's 139-point fall.NEWS25: Stock Market Extends Losses, But These 2 Dow Stocks Are Near Buy Points.NEWS26: The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Pfizer, Qualcomm and Mitsubishi UFJ Financial.NEWS27: 3 Medical Product Stocks Likely to Beat This Earnings Season.NEWS28: Arrowhead Pharmaceuticals Is Flying Higher on the Charts.NEWS29: Pharma Stock Roundup: JNJ's Q3 Earnings, RHHBY's Sales, FDA Nod to Lilly's Reyvow.NEWS30: Options Bears Blast Johnson & Johnson After Baby Powder Recall.NEWS31: For Boeing and Johnson & Johnson: Where There's Smoke, There's Fire.NEWS32: US STOCKS-Wall St treads water as earnings counter China data gloom; J&J falls.NEWS33: Dow Jones Falls In Weak Stock Market Action; Intuitive Surgical Is Breaking Out Today.NEWS34: It’s Crunch Time for an Opioid Settlement Before Key Trial Starts.NEWS35: Johnson & Johnson, American Express share losses lead Dow's 70-point fall.NEWS36: Settling Opioid Suits Probably Won’t End the Crisis.NEWS37: Dow breaks slightly lower at Friday's open as J&J's stock weighs on blue chips.NEWS38: US STOCKS SNAPSHOT-Wall St opens lower as J&J slips.NEWS39: Johnson & Johnson Voluntarily Recalls A Batch Of Baby Powder.NEWS40: Johnson & Johnson's stock drops after baby powder recall.NEWS41: Johnson & Johnson to recall some baby powder as FDA finds traces of asbestos.NEWS42: Johnson & Johnson Consumer Inc. To Voluntarily Recall A Single Lot Of Johnson's Baby Powder In The United States.NEWS43: UPDATE 3-WHO hails 'triumph' as Merck's Ebola vaccine gets European green light.NEWS44: J&J's depression drug Spravato wins European panel vote.NEWS45: The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe.NEWS46: J&J recalls batch of baby powder after asbestos traces found.NEWS47: UPDATE 1-Judge summons drug company CEOs to discuss opioid settlement - source.
2019-10-21: NEWS1: October brings losses for short sellers in U.S. opioid-related shares.NEWS2: Shapiro, state AGs announce tentative $48B national opioid settlement.NEWS3: Drug Companies Strike $48 Billion Deal In Opioid Crisis With Four States.NEWS4: How 16 Blue Chip Stocks Are Getting Squeezed by Strong Dollar.NEWS5: Get Real. There Will Be a Global Opioid Settlement..NEWS6: J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos.NEWS7: Opioid settlement reached with four drug companies: report.NEWS8: How Much Litigation Risk Is Priced Into Johnson & Johnson?.NEWS9: Four companies reach opioid settlement in Ohio.NEWS10: Stock Market News for Oct 21, 2019.NEWS11: McKesson Among Four to Pay Over $250 Million in Opioid Case.NEWS12: 4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain.NEWS13: There’s Still No Global Deal on Opioid Litigation, but Distributors Will Sit Out Monday Trial.NEWS14: UPDATE 9-Drug firms avert landmark opioid trial as talks on $48-bln settlement set to resume.NEWS15: Johnson & Johnson stock pummeled after asbestos-related baby powder recall.NEWS16: Energy Stocks Are Getting Hammered.NEWS17: 5 Stocks Set to Lead Longterm as Fed Rate Cuts Deepen.

Answer: Rise